Skip to content

Surgical decompression versus local steroid injection in carpal tunnel syndrome

Surgical decompression versus local steroid injection in carpal tunnel syndrome: a prospective randomised trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN26264638
Enrollment
100
Registered
2012-02-02
Start date
1998-10-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal tunnel syndrome Nervous System Diseases Carpal tunnel syndrome

Interventions

Local steroid injection versus surgical decompression for new-onset CTS. All surgical procedures are performed on an outpatient basis using a limited palmar incision technique. Local steroid injectio

Sponsors

University Hospital Puerta de Hierro Majadahonda (Spain)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. At least 18 years old 2. Symptoms of CTS of at least 3 months? duration 3. Referred by their primary care physicians to a CTS unit specifically created for this study 4. A presumptive diagnosis of CTS, and had been unresponsive to a course of at least 2 weeks of non-steroidal anti-inflammatory drugs (NSAIDs) and splinting. 5. CTS confirmed by electrodiagnostic testing according to Kimura´s criteria.

Exclusion criteria

Exclusion criteria: 1. Patients with wrists with thenar atrophy 2. Previous carpal tunnel release surgery, or local injection for CTS 3. Patients who are pregnant 4. Patients which have diabetes mellitus 5. Patients which have hypothyroidism 6. Patients which have inflammatory arthropathy 7. Patients which have polyneuropathy

Design outcomes

Primary

MeasureTime frame
Percentage of wrists reaching at least a 20% reduction in the VAS score for nocturnal paresthesias at 3 months of follow up.

Secondary

MeasureTime frame
Percentages of wrists with a 20% reduction in the VAS score for nocturnal paresthesias at 6 and 12 months, a 20% response for pain and functional impairment, as well as a 50% and a 70% response in nocturnal paresthesias, pain, and functional impairment.

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 26, 2026